MEOPA Breathing Analgesia for Oocyte Retrieval(KALOVAL)
KALOVAL
MEOPA Breathing Analgesia vs Local Anesthesia for Oocyte Retrieval in ART: a Prospective, Randomized Controlled Study
1 other identifier
interventional
77
1 country
1
Brief Summary
The purpose of this study is to assess pain, at or after oocyte retrieval, the effectiveness of self-controlled inhalation analgesia by nitrous oxide (N2O of 50% and 50% O2) by the patient compared to a local anesthesia combined with a tablet of 0.5 mg of Alprazolam.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Nov 2008
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2008
CompletedFirst Submitted
Initial submission to the registry
February 6, 2009
CompletedFirst Posted
Study publicly available on registry
March 2, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2011
CompletedSeptember 18, 2012
May 1, 2011
2.2 years
February 6, 2009
September 15, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain after oocyte retrieval at + 30, 60 and 120 minutes.
immediate (at + 30, 60 and 120 minutes)
Secondary Outcomes (3)
Patients satisfaction at time + 120 minutes.
immediate (at + 120 minutes)
Patients recommendation at time + 120 minutes. Patients with supplementary analgesics at time + 120 minutes.
immediate (at time + 120 minutes)
Patients with canceled protocol arm attribution during oocyte retrievalART already stated issues Reactive Oxygen Species in retrieved follicular fluid.
immediate
Study Arms (2)
nitrous oxide
EXPERIMENTALN2O of 50% and 50% O2 MEOPA
lidocaine
ACTIVE COMPARATORInjection solution 1%
Interventions
Eligibility Criteria
You may qualify if:
- patient requiring a first or second oocyte retrieval procedure for IVR or ICSI after ovarian stimulation by gonadotrophin
- agreement to participate to this study
You may not qualify if:
- absolute indication for oocyte retrieval with general anesthesia
- no agreement to participate to this study,
- painfully known patient-not easy ovarian vaginal accessibility for monitoring or puncture
- respiratory pathology-chronic liver, kidney pathology, immunodeficiency, -contraindication to the medications used during the protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Jean Verdier, service de la médecine de la reproduction, avenue du 14 juillet
Bondy, Île-de-France Region, 93143, France
Related Publications (1)
Bauer C, Lahjibi-Paulet H, Somme D, Onody P, Saint Jean O, Gisselbrecht M. Tolerability of an equimolar mix of nitrous oxide and oxygen during painful procedures in very elderly patients. Drugs Aging. 2007;24(6):501-7. doi: 10.2165/00002512-200724060-00006.
PMID: 17571915RESULT
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christophe Poncelet, MD PhD
Assistance Publique - Hôpitaux de Paris
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2009
First Posted
March 2, 2009
Study Start
November 1, 2008
Primary Completion
January 1, 2011
Study Completion
January 1, 2011
Last Updated
September 18, 2012
Record last verified: 2011-05